Cuba sells another 4.5 million doses of Abdala vaccine to Mexico

Cuba sells another 4.5 million doses of Abdala vaccine to Mexico

HAVANA, February 12. More than 4.5 million doses of the Abdala anti-Covid-19 vaccine arrived in Mexico City this Friday, sold by Cuba to the Mexican government as part of an agreement between both nations. According to Mexican authorities, it is a shipment of some four million 530 thousand doses, manufactured by the Center for Genetic and Biotechnological Engineering of Cuba (CIGB), which arrived at the Felipe Ángeles International Airport in the aforementioned city.

In total, since January 26, more than seven million 380 thousand doses of the Abdala vaccine have arrived in Mexico, indicated the Ministry of Health of the Aztec nation.

To this, we should add those that arrived in the second half of 2023, which were more than two million 800 thousand.

Shipments began in 2022 after the signing of several agreements between Mexico and Cuba, which aimed at the purchase of some nine million doses of Abdala to be used in children between five and 11 years old.

With the three-dose scheme, about three million minors could be injected with Abdala. Together with Abdala, Mexico is using vaccines such as Moderna, Pfizer, AstraZeneca, Sinovac, and others, to complete the schedules of its vaccination campaigns, according to official media reports from that nation.

The Ministry of Health recently emphasized that the Cuban vaccine is “safe, effective and of quality.” In addition, he recalled that it is authorized for emergency use and that it will be used to reinforce the 2023-2024 National Winter Vaccination Campaign.

However, the drug has not been endorsed by the World Health Organization. The rest of the Cuban drugs against the coronavirus are in the same situation.

Meanwhile, Abdala was widely used in Cuba, like its “sister” Soberana 02, another Cuban-produced anti-Covid-19 vaccine.